Nektar Therapeutics (NASDAQ:NKTR)

buy sell

Russell 2000 Rebalance May Bring Huge Buying in Key Stocks

Typically when any major index does a rebalancing, there is a large amount of buying and selling that takes place as the index resets to the new percentage assignments for ...
Read Full Story »
biotech

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Anybody that has been long the biotechnology sector for the past four years has had outstanding returns. Following four straight years of outperformance against the S&P 500, investor interest in ...
Read Full Story »
Pills

Piper Jaffray Has Four Biotech Stocks to Buy With Huge Potential

One of the advantages of having wide Wall Street coverage is the ability to constantly screen even the smallest tidbits of research that is put out each day. Many times ...
Read Full Story »
170622870

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

The start of 2014 for the small and mid-cap biopharma group has been torrid. Positive exciting catalysts delivering greater-than-expected (or even in-line) results have rapidly pushed selected names higher. The ...
Read Full Story »
153790263

Nektar Pain Drug Sends Shareholders To Rehab

Nektar Therapeutics (NASDAQ: NKTR) may have just burned a serious bridge for its future. The company is developing drugs for pain management and for cancer, and now its investigational drug ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (AFL, AXP, AINV, ARMH, BIIB, CELG, CS, DELL, GMCR, INFY, LOGI, LYG, MLNX, NKTR, PDLI, PCYC, REGN, RBS, UAL, LCC, VRTX, VPHM, WFT)

These are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a larger concentration around biotech and emerging pharma this morning, but that ...
Read Full Story »

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) ...
Read Full Story »

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  ...
Read Full Story »

24/7 Wall St. Closing Bell (FSLR, MA, WAG, WEN, SD, DVR, EIX, NKTR, SSW, BID, DRC, JRCC, KR, MSO, ARCT, PEGA, CVO, TUDO, FFN)

The three major US equities indexes opened higher this morning after another (small) drop in new unemployment benefits claims and a good, but smaller-than-expected, rise in personal income and spending ...
Read Full Story »

Morning Movers (CEP, NKTR, VOCS, SODA, CZR)

The three major US equities indexes opened higher this morning following a better-than-expected report on US GDP growth (our coverage here) and the $712 billion purchase by eurozone banks in ...
Read Full Story »

Top Active Trader Alert Stocks (BSPM, HBAN, NKTR, NSTC)

Active traders and day traders have many stocks to choose from this Monday morning.  We are tracking news and moves in shares of Biostar Pharmaceuticals, inc. (NASDAQ: BSPM), Huntington Bancshares Inc. (NASDAQ: ...
Read Full Story »

The 52-Week Low Club

IMS Health (RX) Bad numbers and a downgrade. Falls to $21.20 from 52-week high of $33.12.The PMI Group (PMI) Housing and mortgage markets hurt quarter. Falls to $22.80 from 52-week ...
Read Full Story »

Nektar Crushed Under Pfizer’s Boot (NKTR, PFE)

Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would end its involvement in inhaled diabetes drug Exubera and return ...
Read Full Story »

52-Week Lows (July 13, 2007) (ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WON)

Stock Tickers: ACA, AVAV, IDIX, KERX, NKTR, REDE, STAA, TRMP, UBET, WONThe DJIA & S&P 500 Index may have put in new highs today, but as you know there are ...
Read Full Story »

The 52-Week Low Club

Hovnanian (HOV) House of pain for home builders. Down to $17.36 from 52-week high of $36.66.Pulte Homes (PHM) More of the same. Drops to $23.28 from 52-week high of $35.56.Lexmark ...
Read Full Story »